Sanofi’s distribution deals; AstraZeneca to supply US and China independently; Merck KGaA expands in China

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential updates on new builds, collaborations, recalls and more.

Sanofi has secured three deals this week to supply its medicines in India and Korea. On Wednesday, Dr Reddy Laboratories announced it will distribute seven of Sanofi’s vaccines in India, a day after Indian manufacturer Cipla said it will locally distribute six of Sanofi’s central nervous system products. Also on Tuesday, Sanofi unveiled a partnership with SK Bioscience to distribute five of its vaccines in Korea.

AstraZeneca is making plans to supply its medicines independently to the US, Europe and China, CEO Pascal Soriot said in an interview with Bloomberg on Wednesday during the Boao Forum for Asia in China. “We also are building our presence here in China, so we can actually supply Chinese…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks